China SXT Pharmaceuticals...

NASDAQ: SXTC · Real-Time Price · USD
1.60
0.02 (1.27%)
At close: Aug 15, 2025, 3:59 PM
1.60
0.00%
After-hours: Aug 15, 2025, 07:44 PM EDT

China SXT Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-401.28K -401.28K 3.3M 3.3M -4.85M -4.85M -2.22M -2.22M -747.3K -747.3K -2.64M -1.32M -3.09M -1.55M -4.13M -2.06M 1.38M 690.63K
Depreciation & Amortization
78.5K 78.5K 90.28K 90.28K 157.73K 51.38K 70.1K 70.1K 54.98K 54.98K 134.01K 67K 186K 93K 162.49K 81.24K 182.93K 91.46K
Stock-Based Compensation
n/a n/a 176.05K 176.05K n/a n/a 138.64K 138.64K 138.64K 138.64K 1M 1M 162.89K 162.89K n/a n/a n/a n/a
Other Working Capital
-13.8K -13.8K -125.87K -125.87K 204.79K 204.79K 2.28K 2.28K 26.08K 26.08K -1.24M -620.78K 2.07M 1.03M -179.09K 6.78K -4.36K -134.96K
Other Non-Cash Items
186.62K 186.62K -3.91M -3.91M 4.25M 4.36M 1.54M 1.54M 299.22K 299.22K 3.93M 960.65K -913.55K -264.58K 1.76M 996.48K 3.24M 85.69K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 750.5K -845.84K -163.52K n/a 2.37K n/a 325.78K n/a -284.17K n/a 91.48K n/a
Change in Working Capital
-542.42K -542.42K -325.96K -325.96K 149.03K 149.03K 709.48K 709.48K -20.1K -20.1K -909.55K -419.5K 2.81M 1.4M 825.16K 495.47K -2.43M -1.03M
Operating Cash Flow
-678.59K -678.59K -674.24K -674.24K -289.78K -289.78K 234.18K 234.18K -274.56K -274.56K 580.64K 290.32K -312.35K -156.18K -983.05K -491.53K -333.51K -166.75K
Capital Expenditures
n/a n/a -3.53K -3.53K n/a n/a -25.28K -25.28K -10.06K -10.06K -41.35K -20.68K -21.14K -10.57K 26.17K 13.09K -119.22K -59.61K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -8.85M n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.86M n/a 2.86M n/a
Other Investing Acitivies
20.27K 20.27K 6.92K 6.92K 9.82K 9.82K -523 -523 29.71K 29.71K 9.3M 4.65M -9.28M -4.64M 3.13M -4.28M 1.43M 1.43M
Investing Cash Flow
20.27K 20.27K 3.39K 3.39K 9.82K 9.82K -25.81K -25.81K 19.66K 19.66K 9.26M 4.63M -9.3M -4.65M -8.54M -4.27M 2.74M 1.37M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.62M 3.62M 918.65K 918.65K -2.23M -2.23M 7.01M 7.01M -5.53M -5.53M 5.5M 2.75M -3.91M -1.95M 12.13M 6.07M 274.5K 137.25K
Financial Cash Flow
3.62M 3.62M 918.65K 918.65K -2.23M -2.23M 7.01M 7.01M -5.53M -5.53M 5.5M 2.75M -3.91M -1.95M 12.13M 6.07M 274.5K 137.25K
Net Cash Flow
n/a n/a 306.08K 306.08K -5.9M -2.95M 14.39M 4.21M -12.59M -6.29M 15.54M 7.77M -13.33M -6.66M 3.01M 1.5M 3.07M 1.53M
Free Cash Flow
-678.59K -678.59K -677.77K -677.77K -289.78K -289.78K 208.9K 208.9K -284.62K -284.62K 539.29K 269.65K -333.49K -166.74K -956.88K -478.44K -452.73K -226.36K